Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001348362-24-000002

Options or other derivatives

  • Director acquired 12,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Baxter Nicholas W Director 2024-07-26 Grant or award · Stock Options +12,000 52,000 D
Loading xslF345X05/primary_doc.xml…